Anti-mouse CD4-InVivo

目录号：A2101         批次号: A210114

       克隆号：GK1.5

打印

Anti-mouse CD4 (克隆号：GK1.5)可与小鼠CD4结合反应。CD4是T细胞受体（TCR）的协同受体，有助于后续与抗原呈递细胞的交流通讯。

抗体信息

克隆号 GK1.5
免疫原

Mouse CTL clone V4
配制 PBS buffer, pH 6.5
推荐同型对照 Rat IgG2b,κ
应用 In vivo CD4+ T cell depletion,FCM,WB
储存条件
(自收到货起)		 Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles
除菌 0.2 μM filtered
纯度 99%
蛋白浓度 7.27 mg/mL
内毒素 ＜1 EU/mg

客户使用selleck产品的实验数据

Anti-mouse CD4-InVivo在文献中得到引用

Dual impacts of serine/glycine-free diet in enhancing antitumor immunity and promoting evasion via PD-L1 lactylation [ Cell Metab, 2024, S1550-4131(24)00415-7] PubMed: 39577415
Blockage of L2HGDH-mediated S-2HG catabolism orchestrates macrophage polarization to elicit antitumor immunity [ Cell Rep, 2024, 43(6):114300] PubMed: 38829739
HVEM in acute lymphocytic leukemia facilitates tumour immune escape by inhibiting CD8+ T cell function [ Cell Oncol (Dordr), 2024, 10.1007/s13402-024-00959-1] PubMed: 38809326
Human/mouse CD137 agonist, JNU-0921, effectively shrinks tumors through enhancing the cytotoxicity of CD8+ T cells in cis and in trans [ Sci Adv, 2024, 10(34):eadp8647] PubMed: 39178257
Low-dose radiotherapy combined with dual PD-L1 and VEGFA blockade elicits antitumor response in hepatocellular carcinoma mediated by activated intratumoral CD8+ exhausted-like T cells [ Nat Commun, 2023, 14(1):7709.] PubMed: 38001101
Low-dose radiotherapy combined with dual PD-L1 and VEGFA blockade elicits antitumor response in hepatocellular carcinoma mediated by activated intratumoral CD8+ exhausted-like T cells [ Nat Commun, 2023, 14(1):7709] PubMed: 38001101
Oncolytic virus M1 functions as a bifunctional checkpoint inhibitor to enhance the antitumor activity of DC vaccine [ Cell Rep Med, 2023, 4(10):101229] PubMed: 37820722
Oncolytic virus M1 functions as a bifunctional checkpoint inhibitor to enhance the antitumor activity of DC vaccine [ Cell Rep Med, 2023, 4(10):101229] PubMed: 37820722
Engineering irradiated tumor-derived microparticles as personalized vaccines to enhance anti-tumor immunity [ Cell Rep Med, 2023, 4(12):101303.] PubMed: 38029750
Engineering irradiated tumor-derived microparticles as personalized vaccines to enhance anti-tumor immunity [ Cell Rep Med, 2023, 4(12):101303] PubMed: 38029750

禁止用于人体及治疗！